A Clinical Trial to Investigate the Efficacy of a Supplement to Improve and Maintain Cognitive Function and Memory

Last updated: July 25, 2024
Sponsor: Scale Media Inc
Overall Status: Active - Not Recruiting

Phase

N/A

Condition

Brain Function

Dementia

Memory Loss

Treatment

Placebo

MindMD Supplement

Clinical Study ID

NCT06523218
20429
  • Ages 50-75
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

This study will evaluate the efficacy of 1MD Nutrition's MindMD supplement in improving and maintaining cognitive function and memory. The randomized controlled trial will include 50 healthy participants aged 50-75 years, lasting for 3 months. Participants will be randomized to receive either the test product or a placebo.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Age 50-75 years

  • Regular experience of symptoms related to cognitive decline (e.g., forgetfulness,lack of focus, brain fog)

  • Generally healthy without uncontrolled chronic diseases

  • Willingness to avoid certain medications and supplements during the study

Exclusion

Exclusion Criteria:

  • Any medical condition or treatment impacting cognitive ability Mental health orneurological disorders

  • Severe allergies, particularly to soy or other product ingredients

  • Taking blood thinning medication

  • Recent or planned surgeries

  • Major illness in the past three months

Study Design

Total Participants: 50
Treatment Group(s): 2
Primary Treatment: Placebo
Phase:
Study Start date:
May 17, 2024
Estimated Completion Date:
August 17, 2024

Connect with a study center

  • Citruslabs

    Santa Monica, California 90404
    United States

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.